EKE. V. Kungurtsev

E. V. Kungurtsev

*This is an algorithmically generated author record based on publicly available information.

E. V. Kungurtsev has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Hybrid surgery for acute lower limb ischemia

    by I.P. Mikhailov, V.A. Arustamyan, L.S. Kokov, I.A. Eroshkin, B.V. Kozlovsky, E.V. Kungurtsev, N.E. Kudryashova, O.V. Leshchinskaya

    Objective. To analyze treatment outcomes in patients with acute lower limb ischemia. Material and methods. The results of surgical treatment were analyzed in 779 patients with acute lower limb ischemia. Patients were divided into 3 groups depending on revascularization technique (open, endovascular and hybrid). Results. There are advantages of hybrid surgery compared to open and endovascular interventions alone. Conclusion. Hybrid interventions contribute to more complete revascularization of ischemic limbs.

  • Operations in patients with giant false aneurysms of upper-limb arteries (clinical case reports)

    by I.P. Mikhaylov, V.A. Arustamyan, B.V. Kozlovskiy, E.V. Kungurtsev

    Операции у больных с гигантскими ложными аневризмами артерий верхних конечностей (клинические наблюдения)


  • Eversion endarterectomy from common femoral artery bifurcation

    by I.P. Mikhailov, V.A. Arustamyan, I.A. Eroshkin, B.V. Kozlovsky, E.V. Kungurtsev

    Common femoral artery (CFA) bifurcation is a critical arterial segment of the lower extremities. Dos Santos J.C. first described endarterectomy from CFA in 1946. It is still preferable method for many patients with occlusion of CFA bifurcation. Although this technique is common in carotid artery surgery and much less common for atherosclerotic lesion of CFA bifurcation, some authors describe favorable results after eversion endarterectomy. Eversion endarterectomy is preferable if synthetic material and autologous veins are unavailable for repair.

  • Open Access

    Venous Thromboembolic Complications in Patients with Acute Chemical Poisoning

    by M. V. Belova, K. K. Ilyashenko, G. N. Sukhodolova, E. V. Kungurtsev, A. V. Polunin, M. M. Potskhveriya, A. Yu. Simonova

    RELEVANCE. Venous thromboembolic complications (VTEC) occur in patients hospitalized with various pathologies, complicate treatment and increase mortality. This problem has not received enough attention in toxicology.AIM OF THE STUDY. Conduct an analysis of VTEC in patients with acute chemical poisoning (AP).MATERIAL AND METHODS. The hospital patient records and pathological examination reports of 670 patients of the N.V. Sklifosovsky Research Institute for Emergency Medicine who died from VTEC in the period 2016–2022 were retrospectively analyzed. VTEC were confirmed by Doppler ultrasound during life or during pathological examination. Statistical analysis of the data was performed using the IBM computer program SPSS Statistics 26.0.RESULTS. VTEC were diagnosed in 245 patients. The proportion of VTEC increased from 20.2 to 46.7% over the years, and in cases of VTEC caused by psychopharmacological drugs, they were registered in 48.8% of cases. VTEC occurred twice more often in people over 60 years of age and 1.3-fold more often in women. Deep vein thrombosis of the right lower limb was predominant in all types of poisoning, and the prevalence of the lesion was mainly local. Concomitant cardiovascular diseases, oncological diseases, diabetes mellitus, and the development of pneumonia increased the risk of VTEC. Pulmonary embolism was observed in more than a third of cases of VTEC in patients with VTEC caused by psychopharmacological drugs, corrosive substances, and hypotensive and antiarrhythmic drugs.CONCLUSIONS. The characteristics of venous thromboembolic complications in acute chemical poisoning in general is similar to the complications indicated that arise in other pathologies, but has some features caused by the effect of specific chemicals on the body.


  • Open Access

    Acute ischemia of the lower limb in a patient with infective endocarditis under the mask of coronavirus infection

    by I. P. Mikhaylov, V. A. Arustamyan, B. V. Kozlovskij, E. V. Kungurcev

    Despite the fact that significant success has been achieved in the treatment of patients with infective endocarditis (IE), difficulties in clinical practice arise in the diagnosis of this disease. The article analyzes a clinical case of successful treatment of a patient with acute ischemia of the lower extremity due to thromboembolic syndrome in IE, the diagnosis of which was initially regarded as COVID-19. The clinical case occurred during the coronavirus infection (COVID-19) pandemic, and all patients who initially complained of fever were regarded as potentially infected, which, with insufficient examination, masked the clinical picture of infective endocarditis.

  • Open Access

    THROMBOLYTIC AND ANTICOAGULANT THERAPY FOR PULMONARY EMBOLISM: AN EFFECT ON PULMONARY PERFUSION (PART 2)

    by O. V. Nikitina, I. P. Mikhailov, N. Y. Kudryashova, E. V. Migunova, O. A. Alekseyechkina, E. V. Kungurtsev, N. M. Udalova, S. Z. Khusainov, I. B. Kostyuchenko, Н. Е. Кудряшова, et al.

    Background.Perfusion scintigraphy reveals perfusion defects in the occlusion of pulmonary vessels of any caliber and makes it possible to quantify pulmonary blood flow disorders, which allows the method to be used for the comparison of the thrombolytic and anticoagulant therapy efficacy in patients with acute pulmonary embolism.Aim of study .To compare the efficacy of thrombolytic and anticoagulant therapy in the treatment of acute pulmonary embolism in the dynamics of pulmonary perfusion disorders.Study Design.A prospective non-randomized study. The quantitative result of pulmonary perfusion deficiency obtained during perfusion scintigraphy was compared in patients with pulmonary embolism treated with thrombolytics or anticoagulants before treatment and in dynamics. The dynamics was evaluated the next day after administration of thrombolytics and on day 4–5 after initiating anticoagulant therapy. Preliminary analysis of these parameters in the group with anticoagulant therapy a day after the start of administration (by analogy with TLT) revealed no statistically significant differences.Description of the method.Radionuclide and CT studies were performed on a hybrid system SPECT/CT “Discovery NM/CT 670” (GE, USA): perfusion was evaluated with 80–120 MBq of Macrotech 99mTc radiopharmaceutical (RP), CT angiography was performed with 70-100 ml of radiopaque substance “Visipaque.” To determine the total perfusion deficiency, each defect of accumulation with an area equal to the segment was taken as a perfusion deficiency of 5% (subsegmental — 2.5%), equal to the lower lobe — 25%, an area equal to the right lung — 55%, the left lung — 45%. Characteristics of the sample.The perfusion scintigraphy was performed in 381 cases out of 503 patients with a diagnosis of pulmonary embolism of high/intermediate risk of early death, treated in the Intensive Care Unit for Surgical Patients from 2011 to 2016. In 166 cases out of 381, thrombolysis was performed; in 215 cases, an anticoagulant was prescribed. The groups did not differ in age and gender composition: 60±16 years; Me 61 (50; 71) and 62±15 years; Me 63 (53; 74); p=0.22, Mann-Whitney test; men/women: 73/93 and 89/126; p=0.68, the Fisher test.Results of the study.In 96.1% (366/381), perfusion disorders were observed in both lungs; in 3.9% (15/381) there was a unilateral lesion. The comparison of the treatment efficacy was conducted in 169 patients: in 127 cases the next day after introduction of a thrombolytic and in 42 cases on day 4–5 of anticoagulant therapy. In the group with thrombolysis, the initial perfusion deficiency was statistically significantly higher than in the anticoagulant group: 50±10%; Me 50 (40; 60) vs. 39±10; Me 40 (30; 45); pConclusion.The advantage of thrombolysis over anticoagulant therapy was the ability to improve pulmonary blood flow, reduce pulmonary hypertension, and stabilize the patients’ condition quickly. Anticoagulant therapy did not allow this effect to be achieved in a short time: the statistically significant reduction in pulmonary perfusion deficiency occurred only on day 4–5 of treatment and was less significant; the statistically significant regression of pulmonary hypertension did not occur at that time.